Home › Funds › Octagon Capital Advisors LP › COGT

Octagon Capital Advisors LP position in COGT

COGENT BIOSCIENCES INC · Health Care

Octagon Capital Advisors LP reported holding 2,350,000 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$75.2M, representing 10.02% of its reported portfolio and ranking #4 among its reported holdings. Octagon Capital Advisors LP has disclosed COGT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)2.35M sh
Reported value held$75.25M
Portfolio Weight10.02%
First reportedQ3 2024
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Octagon Capital Advisors LP's COGT position evolved

Octagon Capital Advisors LP first disclosed a stake in COGT in Q3 2024 at 1,305,000 shares (US$14.1M). The position peaked in Q2 2026 at 2,350,000 shares, worth US$90.9M. Across 9 filings, Octagon Capital Advisors LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 2,350,000 shares valued at US$75.2M. Notable position changes include a 112% increase in Q4 2024 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.30M $14.09M New
Q4 2024 2.76M $21.55M Add
Q1 2025 2.76M $16.55M Hold
Q2 2025 2.76M $19.84M Hold
Q3 2025 2.87M $41.27M Add
Q4 2025 2.35M $83.47M Reduce
Q1 2026 2.35M $90.45M Hold
Q2 2026 2.35M $90.94M Hold
Q3 2026 2.35M $75.25M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 50 other funds we track also report a position in COGT — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$190.7M), Fairmount Funds Management LLC (US$176.2M), Kynam Capital Management, LP (US$121.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has Octagon Capital Advisors LP held COGT?

Octagon Capital Advisors LP has disclosed COGT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Octagon Capital Advisors LP's current position in COGT?

As of Q3 2026, Octagon Capital Advisors LP holds 2.35M shares of COGT (COGENT BIOSCIENCES INC), valued at $75.25M, representing 10.02% of its reported portfolio and ranking #4.

Has Octagon Capital Advisors LP been buying or selling COGT?

In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP held unchanged its position in COGT. The position peaked in Q2 2026 at 2.35M shares.

Which other funds hold COGT?

Other major institutional holders of COGT include DEERFIELD MANAGEMENT COMPANY, L.P., Fairmount Funds Management LLC, Kynam Capital Management, LP, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.